Safety and efficacy of lanreotide depot versus placebo in neuroendocrine tumor patients with a history of carcinoid syndrome and prior octreotide therapy

Authors
Category Primary study
JournalAmerican Journal of Gastroenterology
Year 2015
This article has no abstract
Epistemonikos ID: 41e6220ea60933aaab16b943d23d325ab4e379d3
First added on: Feb 13, 2025